Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Hollstein

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Molecular Genetics and Metabolism Reports|June 29, 2019
Clinical outcome of a patient with lysosomal acid lipase deficiency and first results after initiation of treatment with Sebelipase alfa: A case reportDominik Soll, Dominik Spira, Tim Hollstein, et al.
Diabetes|April 29, 2020
Metabolic Responses to 24-Hour Fasting and Mild Cold Exposure in Overweight Individuals Are Correlated and Accompanied by Changes in FGF21 ConcentrationTim Hollstein, Sascha Heinitz, Takafumi Ando, et al.
Vascular Pharmacology|March 27, 2019
Treatment with PCSK9 inhibitors reduces atherogenic VLDL remnants in a real-world studyTim Hollstein, Anja Vogt, Thomas Grenkowitz, et al.
MMW Fortschritte Der Medizin|June 26, 2020
Johannes R Bogner, Stefan Esser, Tim Hollstein, et al.
Clinical Chemistry and Laboratory Medicine|February 18, 2025
Evaluation of current indirect methods for measuring LDL-cholesterolSophia Drobnik, Hubert Scharnagl, Nilesh J Samani, et al.
Nature Metabolism|September 4, 2020
Autoantibody-negative insulin-dependent diabetes mellitus after SARS-CoV-2 infection: a case reportTim Hollstein, Dominik M Schulte, Juliane Schulz, et al.
Journal of Lipid Research|October 17, 2018
The interrelations between PCSK9 metabolism and cholesterol synthesis and absorptionGünther Silbernagel, Lars K Steiner, Tim Hollstein, et al.
Frontiers in Immunology|October 31, 2022
Brief Research Report: Serum clara cell 16 kDa protein levels are increased in patients hospitalized for severe SARS-CoV-2 or sepsis infectionNathalie Rohmann, Paula Stürmer, Corinna Geisler, et al.
Cardiovascular Research|July 27, 2021
The size of apolipoprotein (a) is an independent determinant of the reduction in lipoprotein (a) induced by PCSK9 inhibitorsValentin Blanchard, Kévin Chemello, Tim Hollstein, et al.
Scientific Reports|May 13, 2021
Effect of various weight loss interventions on serum NT-proBNP concentration in severe obese subjects without clinical manifest heart failureTim Hollstein, Kristina Schlicht, Laura Krause, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Molecular Genetics and Metabolism Reports|June 29, 2019
Clinical outcome of a patient with lysosomal acid lipase deficiency and first results after initiation of treatment with Sebelipase alfa: A case reportDominik Soll, Dominik Spira, Tim Hollstein, et al.
Diabetes|April 29, 2020
Metabolic Responses to 24-Hour Fasting and Mild Cold Exposure in Overweight Individuals Are Correlated and Accompanied by Changes in FGF21 ConcentrationTim Hollstein, Sascha Heinitz, Takafumi Ando, et al.
Vascular Pharmacology|March 27, 2019
Treatment with PCSK9 inhibitors reduces atherogenic VLDL remnants in a real-world studyTim Hollstein, Anja Vogt, Thomas Grenkowitz, et al.
MMW Fortschritte Der Medizin|June 26, 2020
Johannes R Bogner, Stefan Esser, Tim Hollstein, et al.
Clinical Chemistry and Laboratory Medicine|February 18, 2025
Evaluation of current indirect methods for measuring LDL-cholesterolSophia Drobnik, Hubert Scharnagl, Nilesh J Samani, et al.
Nature Metabolism|September 4, 2020
Autoantibody-negative insulin-dependent diabetes mellitus after SARS-CoV-2 infection: a case reportTim Hollstein, Dominik M Schulte, Juliane Schulz, et al.
Journal of Lipid Research|October 17, 2018
The interrelations between PCSK9 metabolism and cholesterol synthesis and absorptionGünther Silbernagel, Lars K Steiner, Tim Hollstein, et al.
Frontiers in Immunology|October 31, 2022
Brief Research Report: Serum clara cell 16 kDa protein levels are increased in patients hospitalized for severe SARS-CoV-2 or sepsis infectionNathalie Rohmann, Paula Stürmer, Corinna Geisler, et al.
Cardiovascular Research|July 27, 2021
The size of apolipoprotein (a) is an independent determinant of the reduction in lipoprotein (a) induced by PCSK9 inhibitorsValentin Blanchard, Kévin Chemello, Tim Hollstein, et al.
Scientific Reports|May 13, 2021
Effect of various weight loss interventions on serum NT-proBNP concentration in severe obese subjects without clinical manifest heart failureTim Hollstein, Kristina Schlicht, Laura Krause, et al.
Pageof 6